Patheon announces a change to its PDS management structure

Patheon Inc. (TSX: PTI), a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today that Mark J. Kontny, Ph.D., President, Global Pharmaceutical Development Services and Chief Scientific Officer, is no longer with the company, effective as of this date.

Until a replacement has been appointed, Dr. Kontny’s duties will be managed by Patheon’s existing PDS operations team.